Chemical formula: C₂₂H₃₀N₂O₂S Molecular mass: 386.551 g/mol PubChem compound: 41693
Sufentanil is a synthetic, potent opioid with highly selective binding to μ-opioid receptors. Sufentanil acts as a full agonist in μ-opioid receptors. Sufentanil does not induce histamine release.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC Group | Classification | |
|---|---|---|
| N01AH03 | Sufentanil | N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Document | Type | Information Source | |
|---|---|---|---|
| DZUVEO Sublingual tablet | MPI, EU: SmPC | European Medicines Agency (EU) |
Sufentanil is an active ingredient of these brands:
Austria (AT)Brazil (BR)Croatia (HR)
Cyprus (CY)
Estonia (EE)Finland (FI)
France (FR)
Ireland (IE)Lithuania (LT)Malta (MT)
Poland (PL)Romania (RO)
South Africa (ZA)
Spain (ES)
Tunisia (TN)
United States (US)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.